These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/26/2016
2:52 PM ET
Press Release

Repligen to Participate in 13th Annual Craig-Hallum Institutional Investor Conference

5/26/2016

WALTHAM, Mass., May 26, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs, t...

 Continue Reading
5/19/2016
8:40 AM ET
Press Release

Repligen Announces Pricing of $100 Million of 2.125% Convertible Senior Notes due 2021

5/19/2016

WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) (the “Company”) today announced the pricing of an underwritten public offering of $100 million aggregate principal...

 Continue Reading
5/18/2016
4:20 PM ET
Press Release

Repligen Announces Proposed Public Offering of $100 Million of Convertible Senior Notes due 2021

5/18/2016

WALTHAM, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) (the “Company”) has commenced an offering of $100 million aggregate principal amount of Convertible Senior Notes d...

 Continue Reading
5/5/2016
7:30 AM ET
Earnings Release

Repligen Reports First Quarter 2016 Financial Results

5/5/2016

WALTHAM, Mass., May 05, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the...

 Continue Reading
4/29/2016
11:24 AM ET
Press Release

Repligen to Report First Quarter 2016 Financial Results

4/29/2016

WALTHAM, Mass., April 29, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report first quarter 2016 financial results on Thursday, May 5, 2016. The...

 Continue Reading
Displaying 1 to 5 (of 177 releases)
Copyright 2016, © SNL Financial LC  Terms of Use